# Classification of Adenocarcinoma of the Esophagogastric Junction

> **NCT04151524** · — · UNKNOWN · sponsor: **St. James's Hospital, Ireland** · enrollment: 1658 (actual)

## Conditions studied

- Oesophagus Cancer
- Barrett Esophagus
- Siewert Type I Adenocarcinoma of Esophagogastric Junction
- Siewert Type II Adenocarcinoma of Esophagogastric Junction
- Siewert Type III Adenocarcinoma of Esophagogastric Junction

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04151524
- **Lead sponsor:** St. James's Hospital, Ireland
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-10-23
- **Primary completion:** 2019-12-25
- **Final completion:** 2020-02-01
- **Target enrollment:** 1658 (ACTUAL)
- **Last updated:** 2019-11-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04151524

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04151524, "Classification of Adenocarcinoma of the Esophagogastric Junction". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04151524. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*